GR3032891T3 - Signal transmission and tag power consumption measurement circuit for an inductive reader. - Google Patents
Signal transmission and tag power consumption measurement circuit for an inductive reader.Info
- Publication number
- GR3032891T3 GR3032891T3 GR20000400586T GR20000400586T GR3032891T3 GR 3032891 T3 GR3032891 T3 GR 3032891T3 GR 20000400586 T GR20000400586 T GR 20000400586T GR 20000400586 T GR20000400586 T GR 20000400586T GR 3032891 T3 GR3032891 T3 GR 3032891T3
- Authority
- GR
- Greece
- Prior art keywords
- power consumption
- signal transmission
- measurement circuit
- consumption measurement
- tag power
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL103052A IL103052A (en) | 1992-09-03 | 1992-09-03 | Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them |
IL106591A IL106591A (en) | 1992-09-03 | 1993-08-04 | Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3032891T3 true GR3032891T3 (en) | 2000-07-31 |
Family
ID=26322502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000400586T GR3032891T3 (en) | 1992-09-03 | 2000-03-07 | Signal transmission and tag power consumption measurement circuit for an inductive reader. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0588177B1 (el) |
JP (3) | JP3662264B2 (el) |
AT (1) | ATE189262T1 (el) |
AU (1) | AU674523B2 (el) |
CA (1) | CA2105449C (el) |
DE (1) | DE69327693T2 (el) |
DK (1) | DK0588177T3 (el) |
ES (1) | ES2142840T3 (el) |
GR (1) | GR3032891T3 (el) |
IL (1) | IL106591A (el) |
PT (1) | PT588177E (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108584A (en) * | 1994-02-07 | 2008-03-20 | Yeda Res & Dev | Cloning of the interferon-binding protein ALPHA / BETA |
US5821078A (en) | 1992-09-03 | 1998-10-13 | Yeda Research And Development Co. Ltd. | Nucleic acid encoding interferon-α/β binding protein |
IL107378A (en) * | 1993-10-24 | 2005-05-17 | Yeda Res & Dev | SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE |
IL118096A0 (en) * | 1996-05-01 | 1996-09-12 | Yeda Res & Dev | Antibodies against interferon alpha/beta receptor |
EP0859633A2 (en) * | 1996-08-16 | 1998-08-26 | Kurt B. Osther | Method for treating diabetes |
EP1021726B1 (en) * | 1996-08-19 | 2004-12-15 | Shaker, Ghassan I. | Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors |
PL197568B1 (pl) | 1997-12-19 | 2008-04-30 | Applied Research Systems | Kompleks zawierający IFN typu I oraz podjednostkę IFNAR, jego zastosowanie, cząsteczka DNA i wektor ją zawierający, komórka gospodarza transformowana wektorem, kompozycja farmaceutyczna, lek, zastosowanie IFNAR, zastosowanie IFN typu I i podjednostki IFNAR, sposób wytwarzania białka fuzyjnego oraz sposób przedłużania okresu trwałości IFN |
EP1893646A2 (en) * | 2005-06-22 | 2008-03-05 | Genentech, Inc. | Methods and compositions for targeting ifnar2 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88377A (en) * | 1988-11-14 | 1996-09-12 | Yeda Res & Dev | Cloning and expression of a protein which modulates cellular response to type I interferon |
FR2657881A1 (fr) * | 1990-02-05 | 1991-08-09 | Europ Biotechnologie Lab | Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides. |
-
1993
- 1993-08-04 IL IL106591A patent/IL106591A/en not_active IP Right Cessation
- 1993-09-02 AU AU46096/93A patent/AU674523B2/en not_active Expired
- 1993-09-02 ES ES93114084T patent/ES2142840T3/es not_active Expired - Lifetime
- 1993-09-02 PT PT93114084T patent/PT588177E/pt unknown
- 1993-09-02 JP JP24398793A patent/JP3662264B2/ja not_active Expired - Lifetime
- 1993-09-02 DK DK93114084T patent/DK0588177T3/da active
- 1993-09-02 CA CA2105449A patent/CA2105449C/en not_active Expired - Lifetime
- 1993-09-02 EP EP93114084A patent/EP0588177B1/en not_active Expired - Lifetime
- 1993-09-02 AT AT93114084T patent/ATE189262T1/de active
- 1993-09-02 DE DE69327693T patent/DE69327693T2/de not_active Expired - Lifetime
-
2000
- 2000-03-07 GR GR20000400586T patent/GR3032891T3/el unknown
-
2004
- 2004-03-25 JP JP2004090279A patent/JP2004254695A/ja active Pending
-
2005
- 2005-01-12 JP JP2005004934A patent/JP3907661B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2004254695A (ja) | 2004-09-16 |
DE69327693T2 (de) | 2000-09-07 |
CA2105449A1 (en) | 1994-03-04 |
ES2142840T3 (es) | 2000-05-01 |
AU674523B2 (en) | 1997-01-02 |
DK0588177T3 (da) | 2000-05-08 |
AU4609693A (en) | 1994-03-10 |
CA2105449C (en) | 2010-07-20 |
IL106591A0 (en) | 1993-12-08 |
EP0588177B1 (en) | 2000-01-26 |
JP3662264B2 (ja) | 2005-06-22 |
ATE189262T1 (de) | 2000-02-15 |
JP2005162762A (ja) | 2005-06-23 |
DE69327693D1 (de) | 2000-03-02 |
EP0588177A3 (en) | 1994-08-17 |
IL106591A (en) | 2008-03-20 |
JP3907661B2 (ja) | 2007-04-18 |
PT588177E (pt) | 2000-05-31 |
EP0588177A2 (en) | 1994-03-23 |
JPH06220100A (ja) | 1994-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2232281B (en) | Ic card | |
GB9405311D0 (en) | Point-of-sale terminals | |
EP0417648A3 (en) | Ic card | |
EP0417887A3 (en) | Ic card | |
EP0412545A3 (en) | Ic package and ic card incorporating the same thereinto | |
EP0603187A4 (en) | Human lactoferrin. | |
GB2219456B (en) | Integrated circuit amplifiers | |
GB9027148D0 (en) | Magnetic card | |
GB2232490B (en) | Torque-measuring arrangements | |
DE3683022D1 (de) | Gepufferte schaltung zur kompensierung des millerstromes. | |
GR3032891T3 (en) | Signal transmission and tag power consumption measurement circuit for an inductive reader. | |
DE58908705D1 (de) | Schaltungsanordnung zur Produktsummenberechnung. | |
AU2245688A (en) | Card reader | |
AU1283992A (en) | Integrated circuit card | |
GB8925692D0 (en) | Identification circuit | |
GB9303138D0 (en) | Integrated circuit amplifiers | |
GB2279907B (en) | An integrated circuit card | |
DE3880338D1 (de) | Schaltung zur konturkompensation. | |
GB8715959D0 (en) | Field effect transistors | |
EP0416108A4 (en) | Nutritious composition | |
GB9412159D0 (en) | Processing low value animal products | |
GB2267682B (en) | An integrated circuit card | |
GB9400491D0 (en) | Integrated circuit amplifiers | |
AU6524190A (en) | Document reader | |
EP0415061A3 (en) | Cash terminal |